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In this issue of Immunity, Lee et al. (2012) demonstrate a surprisingly broad ‘‘window of opportunity’’ for
regulatory T (Treg) cell induction and provide evidence for an avidity model of Treg cell differentiation versus
deletion.A series of landmark studies in the late
1980s indicated that through positive
and negative selection ‘‘the thymus
selects the useful..and destroys the
harmful’’ (von Boehmer et al., 1989). A
few years later, the aviditymodel of thymic
selection provided a conceptual frame-
work to resolve the apparent paradox
that two diametrically different thymocyte
fates (survival versus death) are both
orchestrated through T cell receptor
(TCR) signals emanating from recognition
of ‘‘self’’ (Jameson et al., 1995). Neverthe-
less, after two decades, we are still far
from a precise understanding of how an
analog input (incrementally varying TCR
signals) is translated into a digital cell-
fate decision (positive or negative selec-
tion). In fact, the situation becomes
even more perplexing with the discovery
that for developing CD4+ T cells there is
yet another TCR-driven developmental
option, namely the differentiation into the
Foxp3+ regulatory T (Treg) cell lineage.
The production of Treg cells is now
generally recognized as ‘‘the third func-
tion of the thymus’’ (Seddon and Mason,
2000).
How do Treg cell differentiation and
clonal deletion relate to each other? There
is little evidence that negative selection
and Treg cell differentiation segregate
in a temporal or spatial manner or differ
in their requirement for a dedicated
antigen-presenting cell (APC)-type. In-
stead, a modified version of the avidity
model has become a popular hypothesis
for explaining the choice between Treg
cell differentiation and clonal deletion
(Simons et al., 2010). Consistent with the
idea that Treg cell differentiation occurs
within an avidity window between positive
and negative selection, a positive correla-
tion between the amount of antigen ex-pressed and the number of emerging
Treg cells is observed in a series of
TCR 3 neo-antigen double-transgenic
systems, whereby ‘‘very high’’ antigen
doses eventually favor deletion (Simons
et al., 2010). Similarly, attenuation of
cognate antigen presentation by medul-
lary thymic epithelial cells (mTECs)
through tissue-specific silencing of major
histocompatibility complex (MHC) class II
diminishes negative selection and in-
creases the emergence of specific Treg
cells (Hinterberger et al., 2010). Because
these studies focused on avidity, several
open questions pertaining to the role of
TCR affinity remain: How do varying TCR
affinities influence thymocyte cell-fate
decisions at a given intensity of antigen
expression? How broad is the range of
TCR affinities that are permissive for
Treg cell differentiation? How do these
parameters relate to the phenomenon
of intraclonal competition between Treg
cell precursors of identical specificity?
In this issue of Immunity, Lee et al.
(2012) report on experiments that address
these questions through TCR ‘‘retro-
genic’’ technology, which allows for the
relatively rapid retroviral introduction of
TCRs into thymocytes or bone marrow
cells. In contrast to previous studies that
mostly used a fixed transgenic TCR
specificity and varied the antigen dose,
Lee et al. pursued an approach that
combines fixed conditions of intrathy-
mic autoantigen expression with varying
TCR affinities (wherein the term ‘‘affinity’’
is used to describe the relative respon-
siveness of a given TCR rather than
true biophysical properties). The authors
use the well-characterized rat insulin
promoter-membrane ovalbumin (RIP-
mOVA) model, in which OVA expression
is specifically and exclusively confinedImmunity 37, Seto mTECs and thereby recapitulates
features of ‘‘promiscuous’’ expression
of peripheral-tissue antigens. Previous
work has shown that these modalities of
OVA expression efficiently induce Treg
cell differentiation of DO11.10 TCR trans-
genic thymocytes, allowing Lee at al. to
employ the DO11.10 TCR as a point of
reference throughout the study.
Using a sophisticated approach in-
volving TCR sequencing of Foxp3+ or
Foxp3CD4+ T cells frommice that trans-
genically express the TCRb chain of the
DO11.10 TCR, the authors selected a total
of eight closely related OVA-specific
TCRs that all contained the b chain of
the DO11.10 TCR and harbored identical
TCRVa and Ja elements, but differed in
one or two amino acid residues within
the TCRa complementarity determining
region 3 (CDR3). When tested for their
dose-response characteristics in vitro,
these TCRs showed a broad distribution
of responsiveness to stimulation with
OVA peptide, with the most sensitive
TCR resembling the DO11.10 TCR,
whereas the least sensitive TCR required
more than 1,000-fold more OVA peptide
for half-maximal stimulation.
Lee et al. (2012) then asked whether
any of these TCRs would mediate OVA-
independent Treg cell differentiation
in vivo. This was done using retroviral
TCR transfer into CD4 CD8 double-nega-
tive thymocytes from Rag2/ mice fol-
lowed by intrathymic injection into wild-
type (WT) mice. Somewhat surprisingly,
three of the TCRs, including the one with
the highest responsiveness to OVA, gave
rise to Treg cells even in the absence
of OVA. However, since all three TCRs
had initially been cloned out of Foxp3+
cells from WT mice, a plausible explana-
tion is that they were cross-reactive toptember 21, 2012 ª2012 Elsevier Inc. 441
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Figure 1. A Broad Range of TCR Affinities
Are Permissive for Treg Cell Differentiation
The model depicts the fate of a clonal cohort of
autoreactive MHC class II-restricted thymocytes
as a function of ‘‘relative TCR affinity’’ when ex-
posed to fixed conditions of autoantigen expres-
sion. Only affinities that lie above the threshold
for positive selection are depicted. The study by
Lee et al. (2012) suggests that the release of
autoreactive T cells is accompanied by the
concomitant emergence of clonally identical Treg
cells over a very broad range of TCR affinities.
The clonal Treg cell niche increases in size with
increasing TCR affinity but even at high ‘‘Treg
cell-permissive’’ affinities may not accommodate
100% of autoreactive cells. Consistent with this
assumption, a substantial overlap between the
TCR repertoires of Treg cells and naive CD4+
T cells is found. The narrow threshold at the
boundary toward affinities that are negatively
selected has been inferred from studies on CD8+
T cell differentiation (Daniels et al., 2006) and
remains to be confirmed for CD4+ T cell differen-
tiation.
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Previewsendogenous self-antigens. The finding
that ‘‘OVA-specific’’ Treg cells can arise
in the absence of OVA is not a trivial
observation (at least for those who do
not think about TCR cross-reactivity on
a daily basis), because it indicates that
high-affinity ‘‘foreign-specific’’ Treg cells
can be educated on self, which has impli-
cations for a variety of settings, such as
infection or vaccination.
Lee et al. (2012) then go on to show
that of the remaining five TCRs that
did not facilitate Treg cell differentia-
tion in WT recipients, four did so when
TCR-transduced precursors were in-
jected into RIP-mOVA thymi. The least
sensitive of these ‘‘Treg cell-promoting’’
TCRs was at least 100-fold less respon-
sive to OVA in vitro when compared to
the DO11.10 TCR. Hence, under fixed
conditions of antigen expression, Treg
cell differentiation can occur over a
remarkably broad range of TCR affinities.
However, the efficacy of Treg cell differ-
entiation was directly proportional to the
TCR affinity, so that a relatively large frac-
tion of cells bearing high-affinity TCRs442 Immunity 37, September 21, 2012 ª2012became Treg cells, whereas only a small
percentage of cells with low-affinity
TCRs did so.
Recent studies in mice transgenically
expressing Treg cell-derived TCRs of
unknown specificity indicated that the
fraction of Foxp3+ cells among clonotype
positive cells inversely correlated with
their precursor frequency (Bautista et al.,
2009; Leung et al., 2009). Conceivably,
parameters such as limited access to
antigen or competition for other permis-
sive and/or instructive factors (e.g., cyto-
kines) in particular thymic microenviron-
ments may be involved in this intraclonal
competition. To address a potential link
between TCR affinity and Treg cell
‘‘niche’’ size, Lee et al. (2012) retrovirally
introduced two OVA-specific TCRs and
the DO11.10 TCR into bone marrow cells
and generated mixed chimeras with
graded doses of TCR transgenic precur-
sors. This confirmed previous work that
showed that Treg cell differentiation
inversely correlates with clonal precursor
frequency, but more importantly, it re-
vealed that at a given precursor fre-
quency, a higher TCR affinity results in
a larger clonal niche. The authors hypoth-
esized that the niche size may be deter-
mined by the number of APCs that
present sufficient antigen to trigger Treg
cell differentiation at the respective TCR
affinity. In this context, it is worth men-
tioning that RIP-driven OVA, like ‘‘true’’
peripheral-tissue antigens, may only be
expressed by a small fraction of mTECs,
so that the chances of antigen encounter
may indeed be a limiting determinant of
Treg cell differentiation.
How do these findings relate to nega-
tive selection? Even with the highest-
affinity TCRs, such as the DO11.10 TCR,
Lee et al. (2012) observed only weak
signs of clonal deletion in the RIP-mOVA
thymus. Therefore, the present work
does not allow for an accurate quantifica-
tion of the ‘‘affinity margin’’ that separates
the minimal requirements for Treg cell
differentiation and negative selection,
respectively. Nonetheless, it appears fair
to conclude that clonal deletion requires
a substantially stronger interaction than
Treg cell differentiation.
The work by Lee et al. (2012) may pave
the way for a more precise quantitative
integration of the parameters that specify
the decision-making by MHC class II-
restricted thymocytes. Clearly, the affinityElsevier Inc.and avidity rules of thymocyte selection,
as they have mostly been established
for MHC class I-restricted thymocytes,
cannot be ‘‘linearly’’ transferred to MHC
class II-restricted T cells. Thus, whereas
for developing CD8+ T cells there appears
to be a very sharp affinity threshold
separating positive and negative selec-
tion (Daniels et al., 2006), it seems that
for CD4+ T cells an additional, surpris-
ingly broad, and in part overlapping
window of opportunity for Treg cell differ-
entiation separates these two options
(Figure 1).
The present work also raises a number
of other questions: What is a low-affinity
Treg cell good for, considering that Treg
cells need TCR stimulation to exert sup-
pressive function? Do precursors carrying
low- and high-affinity TCRs compete for
the same Treg cell niche, and if so,
will high-affinity TCRs out-compete low-
affinity TCRs? An utterly unexpected
finding of Lee et al. (2012) is that at
the lowest precursor frequencies tested
(0.1% of CD4+SP cells), the Treg cell
niche for high-affinity TCRs ‘‘collapses,’’
so that no Treg cell differentiation is
detectable any longer. Future work is
needed to explain this observation, in
particular in light of the fact that this
experimental frequency of 1 in 1,000 still
far exceeds recent estimates of the phys-
iological frequency of antigen-specific
thymocytes in the polyclonal repertoire
(Moon et al., 2011). In sum, the study by
Lee et al. provides strong evidence in
favor of an avidity model of Treg cell
differentiation versus negative selection
and sheds novel light on how the thymus
not only selects the useful and destroys
the harmful, but also fulfills its third essen-
tial function: turning harmful cells into
useful ones.REFERENCES
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Foxp3+ Treg cells express transcription factors normally expressed by specific T helper cells at sites of
inflammation. In this issue of Immunity, Koch et al. (2012) and Hall et al. (2012) demonstrate that IFN-g and
IL-27 distinctly induces T-bet+ Treg cells via STAT-1 transcription factor activation.CD4+ T cells are important for host
defense in their role as specialized T
helper (Th) cell subsets (e.g., Th1, Th2,
Th17, and Tfh), which express specific
transcription factors, such as T-bet,
Gata3, IRF4, RORgt, and BCL-6. Foxp3+
regulatory T (Treg) cells, in contrast, are
indispensable for the maintenance of
immune tolerance and homeostasis via
mainly controlling the development and
expansion of these Th cell populations
(Sakaguchi et al., 2008). Recent studies
have shown that Foxp3+ Treg cells are
able to sense cytokine signals in the
environment and further differentiate to
control specific type of inflammation via
expressing transcription factors specifi-
cally associated with the differentiation
and function of Th cell subsets. In this
issue of Immunity, Koch et al. (2012) and
Hall et al. (2012) demonstrate that T-bet+
Treg cells, one of such specialized Treg
cell subpopulations, are induced in
a STAT1-dependent manner by exposure
to the cytokine IFN-g or IL-27 and that
each cytokine has distinct roles in driving
T-bet+ Treg cells at inflammation sites.
The transcription factor T-bet, normally
required for Th1 cell development, is
upregulated in Treg cells in response to
IFN-g, and T-bet-deficient Treg cells fail
to rescue Foxp3-deficient mice from
Th1 cell-mediated inflammatory disease
(Koch et al., 2009). T-bet induces the
Th1 cell-associated chemokine receptorCXCR3, which enables the T-bet+ Treg
cells to migrate to a type 1 inflammation
site and suppress local Th1 cell immune
responses. Similarly IRF4+ Treg cells
control type 2 inflammation: Treg-specific
deletion of Irf4, which is critical for Th2
cell differentiation, results in the failure
of these Treg cells to efficiently sup-
press Th2 cell-mediated immunopa-
thology (Zheng et al., 2009). In addition,
Treg cell-specific deficiency of the tran-
scription factor STAT3, which is essential
for proper development of Th17 cells, fails
to suppress Th17 cell-mediated disease,
indicating the role of STAT3+ Treg cells
in controlling Th17 cell immune responses
(Chaudhry et al., 2009). Thus, the ability of
Foxp3+ Treg cells to control different
types of Th cell responses crucially
depends on their expression of specific
Th cell-associated transcription factors.
Key issues are then how they acquire
such inflammation type-specific suppres-
sive activities and how the activities are
maintained during inflammation.
In this issue, Koch et al. (2012) have
investigated the molecular pathway lead-
ing to the upregulation of T-bet in Foxp3+
Treg cells and explored possible mecha-
nisms by which T-bet+ Treg cell function
ismaintained in Th1 cell-polarizing inflam-
matory environments. They showed that
activation of STAT1 by IFN-g derived
from activated Th1 cells induced T-bet
expression in Treg cells. Notably, despitesimilar induction of CXCR3 expression in
both Foxp3+ and Foxp3 T cells via
T-bet activation, the levels of IL-12 re-
ceptor expression were different between
the two populations. The expression of
the receptor component IL-12Rb2, which
is induced in naive T cells after STAT1 and
T-bet activation, was refractory to T-bet
expression in Foxp3+ Treg cells in part
because of altered epigenetic status of
Il12rb2 locus in Treg cells. This prevented
T-bet+ Treg cells from completing IL-12-
STAT4-dependent Th1 cell differentiation
and thereby ensured their maintenance
of stable suppressive function without
producing pro-inflammatory Th1 cyto-
kines (Figure 1).
Hall et al. (2012) showed that not only
IFN-g but also IL-27 was able to activate
STAT1 in Treg cells, promote their expres-
sion of T-bet and CXCR3, and expand
such T-bet+CXCR3+ Treg cells. Previous
studies showed that IL-27, an inhibitory
cytokine in the setting of autoimmunity
and inflammation, did not alter Treg cell
suppressive activity and that the fre-
quency of Treg cells was not significantly
changed in IL-27Ra-defiecient mice
(Villarino et al., 2003). Interestingly, Hall
et al. (2012) showed that IL-27 deficiency
resulted in significant reduction of
T-bet+CXCR3+ Treg cells in the gut-asso-
ciated lymphoid tissues (GALTs), but not
in the spleen, during oral Toxoplasma
gondii infection, which induced Th1ptember 21, 2012 ª2012 Elsevier Inc. 443
